Trending Stories on Eyewire+

Trending Stories on Eyewire+


Eylea HD Phase 3 Trial Meets Primary Endpoint in Patients with RVO

Regeneron announced the primary endpoint was met in the phase 3 QUASAR trial investigating Eylea HD (aflibercept) injection 8 mg for the treatment of patients with macular edema following retinal vein occlusion (RVO), including those with central, branch and hemiretinal vein occlusions.

In the trial, patients treated with Eylea HD every 8 weeks (after initial monthly doses) experienced... Read More


Vabysmo Prefilled Syringe (PFS) Approved in the EU

The European Medicines Agency (EMA) has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of wet age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). 

“Approval of the Vabysmo prefilled syringe in the EU offers a convenient way for ophthalmologists to... Read More


Glaukos Submits New Drug Application to FDA for Epioxa

Glaukos announced it has submitted a new drug application (NDA) to the FDA for Epioxa (Epi-on), its next-generation corneal cross-linking iLink therapy for the treatment of keratoconus.

“The NDA submission for Epioxa represents an important milestone for our company as it brings us one step closer in... Read More


EyewireTV | 12.18.2024

Bausch + Lomb makes an acquisition to expand its glaucoma surgical offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices Click here to check it out!


Latest In Podcasts


Why choose Pediatric Ophthalmology? Medical Student, Resident, & Attending Perspectives

Cohosts Jennifer Galvin, MD; Alexander Valentine, MD; and medical student Angela Ngo invite Courtney Kraus, MD, to the podcast to discuss what drew her to pediatric ophthalmology and what a typical week looks like in her pediatric and adult strabismus practice. She reviews her experience with the anterior segment in these patients and her approach to pediatric cataracts and glaucoma management. Click here to catch the latest episode.



86. Cornea Chronicles Part 1: Becoming a Specialist ft. Dr. Sophia Leung

In this episode, we sit down with Dr. Sophia Leung, an exceptional Optometrist specializing in cornea and anterior segment disease. Part one dives into Dr. Leung’s journey to becoming a cornea specialist, including her transition from private practice to a residency in Oklahoma, relationships she’s developed working alongside ophthalmology, and a day in the life as a corneal specialist in Calgary, Alberta. Catch the latest episode here!


Eyewire News: The Podcast

Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Catch the latest episodes here!


Latest in Subspecialties:

CATARACT: History of the Loose Cataract

REFRACTIVE: VJCRGS Introduction: Volume 40, Issue 4

GLAUCOMA: B+L Bolsters Glaucoma Offerings with Elios Acquisition

RETINA: Switching from Aflibercept to Faricimab in Wet AMD Patients

OPTOMETRY: What’s New in Presbyopia-Correcting Eye Drops

Thank you for reading! We'll be back next week with another edition of Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+.


To view or add a comment, sign in

More articles by Eyewire+

Insights from the community

Others also viewed

Explore topics